Important Information

and 20th Anniversary Celebration
November 12-15, 2014
Realizing the Dream of Precision Medicine
With special address by Dr. Francis Collins

Corporate Workshop Day
November 12, 2014

Special Address by Dr. Francis Collins
November 12, 2014

Molecular Pathology Outreach Course
November 12, 2014

Exhibit Dates
November 13-15, 2014

Gaylord National Resort & Convention Center
National Harbor, MD
(Just outside Washington, DC)

Early (Reduced) Registration
September 10, 2014
Advance Registration
October 20, 2014
Hotel Reservations
October 20, 2014

How to Help

Corporate Support Opportunities
Donate to AMP


Linked In FaceBook Twitter
Project management using Podio


more information

Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters





AMP Position statements and letters

AMP Position Statements and Letters - 2010


2010 Title Keywords Committee


Comments to the SACGHS re: Whole Genome Sequencing


Whole Genome Analysis Working Group


Letter to FDA Expressing Concerns Over Potential Medical Device Registration Requirement


Multi-Association Coalition



Letter to FDA Encouraging Continued Dialogue re: LDTs


Multi-Association Coalition



Comments to NIH regarding the Genetic Test Registry


Professional Relations


Comments to FDA regarding oversight of laboratory developed tests


Professional Relations






Comments to SACGHS regarding the draft report on Genetics Education and Training


Professional Relations


Comments to FDA regarding regulation of cytogenetic arrays


Arrays Working Group


Comments to FDA CDRH Council regarding barriers to market for molecular diagnostic tests


Professional Relations


Comments to SACGHS regarding Whole Genome Sequencing


Clinical Practice






Comments to the SACGHS to finalize gene patent report and recommendations as presented in October 2009


Professional Relations





  Comments to AHRQ on the draft Technology Assessment, "Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment"   Professional Relations


AMP's position on the oversight of laboratory developed tests (LDTs) released and discussed with FDA


Professional Relations


AMP presents to MEDCAC regarding pharmacogenomic testing


Professional Relations